Foley & Lardner LLP Partner Jessica Lochmann is quoted in the Law360 article, “New Buyback Rules Put Companies’ Motives Under Spotlight,” discussing new disclosures mandated by the U.S. Securities and Exchange Commission that will see greater scrutiny placed upon company buyback programs.
Companies should prepare to justify their buyback programs in greater detail, and Lochmann said to limit liability for misleading disclosures, corporate executives and boards should carefully examine whether their communications on buyback policies are materially accurate and complete.
“And those reasons and rationales may change over time,” Lochmann added. “I don’t think that language should be boilerplate.”
(Subscription required)
People
Related News
13 January 2025
In the News
Matthew Krueger Assesses Government Health Care Enforcement Focuses for 2025
Foley & Lardner LLP partner Matthew Krueger assessed several key government health care enforcement targets for the year ahead in the Report on Medicare Compliance article, "Outlook 2025: Look for MA Cases Based on Claim Denials; Incoming DOJ May Tweak Guidance," published by the Health Care Compliance Association.
13 January 2025
In the News
Aaron Maguregui on HHS Cybersecurity Revamp – 'Going to be added costs across the board'
Foley & Lardner LLP partner Aaron Maguregui assessed the U.S. Department of Health and Human Services' (HHS) proposed overhaul of its cybersecurity rules in the Bloomberg Law article, "Health Supply-Chain Hacks Targeted by HHS Cybersecurity Rule."
13 January 2025
In the News
Judith Waltz Describes Potential Health Policy Changes Under New Administration
Foley & Lardner LLP partner Judith Waltz commented on potential health policy changes under the incoming presidential administration in the Report on Medicare Compliance article, "Outlook 2025: Disruption Is Expected, Along With More OIG Guidance, Payment Changes," published by the Health Care Compliance Association.